146 related articles for article (PubMed ID: 37784000)
1. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Otani K; Sawazaki S; Cho H; Morita J; Kawahara S; Tanabe M; Yukawa N; Saito A; Ogata T; Rino Y; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):402-409. PubMed ID: 37889434
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
Pang H; Dai L; Chen L; Chen X; Chen Z; Zhang S; Sun H
BMC Cancer; 2024 May; 24(1):583. PubMed ID: 38741082
[TBL] [Abstract][Full Text] [Related]
8. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
[TBL] [Abstract][Full Text] [Related]
9. The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
11. The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kamiya N; Kato A; Yamada T; Nagasawa S; Kawahara S; Cho H; Morita J; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
Anticancer Res; 2023 Nov; 43(11):5181-5187. PubMed ID: 37909998
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study.
Huang YY; Liu X; Liang SH; Hu Y; Ma GW
BMC Cancer; 2022 Nov; 22(1):1183. PubMed ID: 36397047
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
Fang KH; Lai CH; Hsu CM; Huang E; Tsai MS; Chang GH; Lee YC; Tsai YT
PeerJ; 2020; 8():e9361. PubMed ID: 32587804
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein/albumin ratio predicts survival after curative surgery in elderly patients with colorectal cancer.
Tamai K; Okamura S; Makino S; Yamamura N; Fukuchi N; Ebisui C; Inoue A; Yano M
Updates Surg; 2022 Feb; 74(1):153-162. PubMed ID: 33677820
[TBL] [Abstract][Full Text] [Related]
15. Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases.
Sakamoto Y; Mima K; Imai K; Miyamoto Y; Tokunaga R; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Baba H
Surg Oncol; 2020 Dec; 35():243-248. PubMed ID: 32932221
[TBL] [Abstract][Full Text] [Related]
16. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
17. Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil.
Hashimoto I; Kano K; Onuma S; Suematsu H; Nagasawa S; Kanematsu K; Furusawa K; Hamaguchi T; Watanabe M; Hayashi K; Furuta M; Inokuchi Y; Machida N; Aoyama T; Yamada T; Rino Y; Ogata T; Oshima T
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373912
[TBL] [Abstract][Full Text] [Related]
18. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.
Miyazaki T; Saji H; Nakamura H; Nagayasu T; Okumura N; Tsuchida M; Sonobe M; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M; Yoshino I;
Surg Today; 2022 Oct; 52(10):1463-1471. PubMed ID: 35211804
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
